In adults 65 years of age and older, Capvaxive covers the serotypes responsible for approximately 85% of IPD cases. Keytruda receives third endometrial carcinoma indication and the 40th ...
The Food and Drug Administration (FDA) has approved pharmaceutical company Merck’s (NYSE:MRK) new vaccine, Capvaxive. This pneumococcal conjugate vaccine is designed to prevent invasive ...
Some results have been hidden because they may be inaccessible to you